The government is expanding its investigation into medical centers that falsely bill for Covid-19 treatment to the entire nation. The investigation will cover 8,423 medical institutions nationwide, from tertiary general hospitals to neighborhood clinics that treat Covid-19 patients.The National Heal
Celltrion said it has received marketing approval from the Japanese Ministry of Health, Labor, and Welfare for Yuflyma, a biosimilar referencing Humira (ingredient: adalimumab).Humira, the original medicine, is prescribed primarily for autoimmune diseases such as rheumatoid arthritis, inflammatory b
Daewon Pharmaceutical said Monday the company has signed a contract with PT Interbat, an Indonesian pharmaceutical company, for the exclusive export and supply of finished products of non-steroidal anti-inflammatory drugs (NSAIDs), Pelubi SR Tab (pelubiprofen).The contract's total value is $3 millio
AbClon said Monday the company would expand its phase 2 clinical trial for its chimeric antigen receptor T-cell (CAR-T) therapy candidate, AT101. to seven sites.In addition to Asan Medical Center, Ajou University Hospital, Ulsan National University Hospital, and Dong-A University Hospital, where the
Dongkook Pharmaceutical is drawing the industry’s attention by completing the phase 3 clinical trial of its new therapy for benign prostatic hyperplasia (BPH), which combines dutasteride and tadalafil.Dongkook Pharm said Monday that it has confirmed the efficacy and safety of DKF-313, an improved co
Janssen, which will launch the first generic version of prostate cancer treatment Zytiga (abiraterone acetate) with insurance benefit, has introduced Akeega, a prostate cancer therapy combining the existing abiraterone and PARP inhibitor niraparib, in Korea.On Monday, the Ministry of Food and Drug S
Philips Korea said on Tuesday that it installed its digital pathology solution at Konyang University Hospital, making the hospital the first university hospital in the central part of Korea equipped with a full digital pathology system.Philips IntelliSite Pathology Solution is a digital pathology im
Novo Nordisk Korea said it showcased its innovative Mallya Smart Sensor technology, a diabetes management solution, at the Korea Digital Future Innovation Exhibition 2023, being held at COEX, Seoul, from Monday to Wednesday this week.The Denmark-based company's new smart sensor promises to revolutio
The latest results of a new treatment for epithelial growth factor receptor (EGFR)-mutant lung cancer that has acquired resistance to current targeted therapies are drawing attention.On Monday, a research team led by Dr. Cho Byoung-chul Cho, a professor at Yonsei University Lung Cancer Center, annou
Last year, 1,066 people were infected with HIV/AIDS, a 9.3 percent increase from the previous year. Five people were infected through the shared use of narcotics.Rep. Choi Young-hee of the People Power Party analyzed data on the status of AIDS infection in the last five years submitted by the Korea
Pinotbio, a local biotech specializing in antibody-drug conjugates (ADC), said it has been selected for a major ADC development project sponsored by the Korea Drug Development Fund (KDDF).The initiative, named the "Global Blockbuster ADC Anticancer Drug Component Development Project," aims to suppor
EyeGene said on Friday in a public filing that its phase 2 clinical trial of EG-Myocin, a drug candidate for the treatment of myocardial ischemia and reperfusion injury, failed to show statistically significant changes in myocardial infarction size. The study explored the effectiveness and safety of
Starting in October, the reimbursement standards for the spinal muscular atrophy (SMA) drugs Spinraza (nusinersen) and Evrysdi (risdiplam) will be expanded and newly established.The Ministry of Health and Welfare (MOHW) issued an administrative notice on the “Partial amendment to the details (pharma
Korea’s attraction of foreign patients is recovering from the Covid-19 pandemic. However, visits by patients from the Middle East, who come here to treat relatively serious diseases instead of skin, beauty, and plastic surgery, are slow to recover, medical sources said.Especially slow is the recover
Plastic surgeons criticized a recent case where a patient in his 50s reportedly lost vision in one eye following an under-eye fat repositioning surgery at a renowned plastic surgery hospital in Sinsa-dong, southern Seoul.The hospital, established in 2004, is also famous for seeing a lot of foreign p
Celltrion Healthcare said on Monday it won bids in major European countries for three of its anti-cancer biosimilars, Truxima (ingredient: rituximab), Herzuma (ingredient: trastuzumab), and Vegzelma (ingredient: bevacizumab), since switching to direct sales. On the same day, Celltrion also announced
Riddled with issues barring effective pediatric care, the Ministry of Health and Welfare (MOHW) said on Friday that it prepared follow-up measures to prevent the collapse of pediatric care including doubling the night-time pediatric consultation fee and increasing pediatric hospital facility budgets
Neurofibromatosis is a rare inherited disease caused by abnormalities in the NF1-NF2 genes, which causes tumors to form in various parts of the body, including the skin of exposed areas, such as the face, neck, hands, and feet. Most tumors caused by neurofibromatosis are benign, but about 2-5 percen
The Korean Society of Heart Failure (KSHF) celebrated its 20th anniversary amid mounting calls from society members to reclassify heart failure as a severe illness.Founded in 2003 as a research committee under the Korean Society of Cardiology, the KSHF was elevated to an independent society in March
Since the government implemented its pilot project of non-face-to-face treatment a month ago, 842 prescriptions for narcotics have been made, although they are prohibited in the non-contact treatment.Some experts point out that non-face-to-face medical treatment has become a channel for the misuse o